Sildenafil Citrate
Product Images NDC 42543-005

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 42543-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vensun Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Each tablet of Sildenafil contains 20mg of sildenafil citrate. It is a medication used for the treatment of erectile dysfunction. The usual dosage for the medication can be found in the accompanying prescription information. The medication needs to be stored between 20°-25°C (68°-77°F) and should be kept away from children. Sildenafil is manufactured by Vensun Pharmaceuticals, Inc. and dispensed by pharmacists in tight containers. The product is manufactured by Rubicon Research Private Limited in Maharashtra, India.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

This is a list of recommended nodose adjustments for several drugs, as well as their AUC and Cmax values, based on interacting drug fold change and 90% CI recommendations. There is also a reference to a study on the lack of exercise capacity benefit when Sildenafil is added to Bosentan therapy. The text contains several errors and misspellings and is difficult to read in some instances.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

This is a drug interaction chart, providing information on how acenocoumarol interacts with several other drugs. The table presents the different medications along with their respective fold change and 90% CI recommendation. The table provides guidance on whether there is a need for adjusting dosage levels or not. There is also information on the effect of drugs on exercise capacity, and a warning about co-administration of some drugs.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

This is a table displaying the change in meters from baseline at 4, 8, and 12 weeks for a study involving a placebo group and groups receiving different doses of sildenafil (20mg, 40mg, and 80mg taken three times a day). There is no further information or context.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

This appears to be a medical report on the effectiveness of Sildenafil in treating Idiopathic PAH. The study includes a sample of subjects with diverse characteristics such as age, gender, and medical history. The report presents measured values for several variables including Baseline walk distance, Mean PAP, and Placabo-corrected Change in 6-Minute Walk Distance.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.